Frontiers in Genetics (Jan 2023)
Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
- Yanbing Yang,
- Xuenian Ye,
- Haibin Zhang,
- Zhaowang Lin,
- Min Fang,
- Jian Wang,
- Yuyan Yu,
- Xuwen Hua,
- Hongxuan Huang,
- Weifeng Xu,
- Ling Liu,
- Zhan Lin
Affiliations
- Yanbing Yang
- Department of Radiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
- Xuenian Ye
- Department of Orthopedics, Dongguan People’s Hospital, Dongguan, China
- Haibin Zhang
- Department of Orthopedics, Dongguan People’s Hospital, Dongguan, China
- Zhaowang Lin
- Department of Radiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
- Min Fang
- Department of Radiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
- Jian Wang
- Department of Radiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
- Yuyan Yu
- Department of Radiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
- Xuwen Hua
- Department of Radiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
- Hongxuan Huang
- Department of Orthopedics, Dongguan People’s Hospital, Dongguan, China
- Weifeng Xu
- Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
- Ling Liu
- Department of Radiology, The First Affiliated Hospital of Dali University, Dali, China
- Zhan Lin
- Department of Radiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
- DOI
- https://doi.org/10.3389/fgene.2023.1146199
- Journal volume & issue
-
Vol. 14
Abstract
No abstracts available.Keywords
- transcription factor
- high mobility group AT-hook protein 1
- MAF BZIP transcription factor G
- prognosis
- therapeutic response
- hepatocellular carcinoma
